• linkedin
  • Increase Font
  • Sharebar

    Proposed bill targets prostate cancer misdiagnoses

    Legislation would authorize CMS to pay for backup DNA tests


    Bill would lead to decrease in spending

    Dr. Bucshon said that under the bill, the lab performing the test would bill CMS as any lab would normally do for any other test, and that eliminating misdiagnosis “will save on average over $10,000 per procedure, resulting in a net decrease in Medicare spending.”

    While there have been suggestions that getting a second diagnosis, which Medicare does pay for, would cost less than the $200 per DSPA test, Dr. Bucshon said, “The bill is aimed at the specific problem of misdiagnosing prostate cancer through additional lab testing to ensure results are accurate and not contaminated. Questions on next steps and second opinions are medical in basis and should be directed at specialists that are well versed in urology, such as the American Urological Association.”

    Also see: Urologists, lawmakers share experience, expertise at AACU event

    The AUA, in a letter in July that was cosigned by the Men’s Health Network and the Prostate Health Education Network, urging Congress to approve Dr. Bucshon’s bill, said, “To deprive Medicare beneficiaries of access to an important test which eliminated medical errors is contrary to the best interests of patients.”

    What’s the outlook for the legislation?

    Said Dr. Bucshon, “The bill passed unanimously through the Energy and Commerce Committee and we are working with the committee to find the best path forward. We are also working to find bipartisan support for a companion bill in the Senate.”

    Most likely, if the bill is to move forward, that will happen in the second session of Congress, which begins in January.

    More from Urology Times:

    Do you ‘feel the Bern’? What a single-payer system portends

    Survey: Urologists weigh in on MIPS, APMs, burnout

    Bill would lift Stark barriers to APMs

    Subscribe to Urology Times to get monthly news from the leading news source for urologists.

    Bob Gatty
    Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available